These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 15810177)

  • 1. Federal office on protecting human subjects issues new decision charts.
    Maloney DM
    Hum Res Rep; 2004 Dec; 19(12):1-2. PubMed ID: 15810177
    [No Abstract]   [Full Text] [Related]  

  • 2. Spate of suspensions of academic research spurs questions about federal strategy: a U.S. agency, its own future uncertain, unsettles college officials with its crackdown.
    Brainard J
    Chron High Educ; 2000 Feb; 96(22):A29-30, A32. PubMed ID: 15744907
    [No Abstract]   [Full Text] [Related]  

  • 3. A review of OHRP compliance oversight letters.
    Borror K; Carome M; McNeilly P; Weil C
    IRB; 2003; 25(5):1-4. PubMed ID: 14870724
    [No Abstract]   [Full Text] [Related]  

  • 4. Beyond compliance...is it too much to ask?
    Koski G
    IRB; 2003; 25(5):5-6. PubMed ID: 14870726
    [No Abstract]   [Full Text] [Related]  

  • 5. New recommendations for protecting children as human research subjects.
    Maloney DM
    Hum Res Rep; 2004 Nov; 19(11):1-2. PubMed ID: 15675086
    [No Abstract]   [Full Text] [Related]  

  • 6. Protecting human research subjects: ten common problems.
    Puglisi T
    Health Law News; 2000 Jun; 13(3):8, 15. PubMed ID: 12542046
    [No Abstract]   [Full Text] [Related]  

  • 7. New federal guidance adds duties for institutional review boards (IRBs).
    Maloney DM
    Hum Res Rep; 2005 Nov; 20(11):1-2. PubMed ID: 16358479
    [No Abstract]   [Full Text] [Related]  

  • 8. New guidance on when and how to report human research problems.
    Maloney DM
    Hum Res Rep; 2005 Jul; 20(7):1-2. PubMed ID: 16270442
    [No Abstract]   [Full Text] [Related]  

  • 9. SACHRP recommendations for review of children's research requiring DHHS secretary's approval.
    Fisher CB; Kornetsky SZ
    IRB; 2005; 27(3):8-10. PubMed ID: 16021795
    [No Abstract]   [Full Text] [Related]  

  • 10. Searching for "research involving human subjects"--What is examined? What is exempt? What is exasperating?
    Pritchard IA
    IRB; 2001; 23(3):5-13. PubMed ID: 11789525
    [No Abstract]   [Full Text] [Related]  

  • 11. New guidelines for protection of subjects who are prisoners.
    Maloney DM
    Hum Res Rep; 2003 Jul; 18(7):3. PubMed ID: 15119337
    [No Abstract]   [Full Text] [Related]  

  • 12. Protecting vulnerable research subjects: practical realities of institutional review board review and approval.
    Wichman A
    J Health Care Law Policy; 1998; 1(1):88-104. PubMed ID: 15573431
    [No Abstract]   [Full Text] [Related]  

  • 13. Conflict + interest: financial incentives and informed consent in human subject research.
    Benbow S
    Notre Dame J Law Ethics Public Policy; 2003; 17(1):181-215. PubMed ID: 14986653
    [No Abstract]   [Full Text] [Related]  

  • 14. How to interpret the federal policy for the protection of human subjects or "Common Rule" (Part A). [for the Working Group of the Human Subjects Research Subcommittee of the National Science and Technology Council].
    Shelton JD
    IRB; 1999; 21(6):6-9. PubMed ID: 11697393
    [No Abstract]   [Full Text] [Related]  

  • 15. Recurrent issues in the review of medical research on human subjects.
    Moore DL
    Albany Law J Sci Technol; 1991; 1():1-33. PubMed ID: 16296123
    [No Abstract]   [Full Text] [Related]  

  • 16. New waiver of regulations on research with prisoner-subjects.
    Maloney DM
    Hum Res Rep; 2003 Aug; 18(8):1-2. PubMed ID: 15119338
    [No Abstract]   [Full Text] [Related]  

  • 17. Case study: university finally can resume human subjects research again.
    Maloney DM
    Hum Res Rep; 2006 Aug; 21(8):6-7. PubMed ID: 17058815
    [No Abstract]   [Full Text] [Related]  

  • 18. Recommendations for federal "super agency" would affect institutional review boards.
    Maloney DM
    Hum Res Rep; 2001 Feb; 16(2):1-3. PubMed ID: 12530378
    [No Abstract]   [Full Text] [Related]  

  • 19. The flip of the coin: exempt, expedited, or full IRB review?
    Bliss-Holtz J
    AACN Adv Crit Care; 2007; 18(2):213-7. PubMed ID: 17473550
    [No Abstract]   [Full Text] [Related]  

  • 20. Institutional review boards (IRBs) failed to use steps to protect vulnerable research subjects.
    Maloney DM
    Hum Res Rep; 2003 Jun; 18(6):6-7. PubMed ID: 15119342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.